The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

Alzheimer's Research and Therapy

Volumn 6, Issue 4, 2014, Pages

  Donaghy, Paul C ^a   McKeith, Ian G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALPHA SYNUCLEIN; BIOLOGICAL MARKER; AMYLOID BETA PROTEIN; DOPAMINE TRANSPORTER;

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR DISORDER; BRAIN STEM; CELL DEATH; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; DIFFUSE LEWY BODY DISEASE; EARLY DIAGNOSIS; HALLUCINATION; HEART SCINTISCANNING; HUMAN; HYPOSMIA; INTESTINE INNERVATION; MEMORY DISORDER; MENTAL DISEASE; MOTONEURON NUCLEUS; NEUROPATHOLOGY; OLFACTORY BULB; OLFACTORY DISCRIMINATION; PARKINSONISM; PATHOPHYSIOLOGY; PHYSICAL DISEASE; POSITIONAL DIZZINESS; PRIORITY JOURNAL; PRODROMAL SYMPTOM; RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER; REM SLEEP; REVIEW; SKIN BIOPSY; SUBSTANTIA NIGRA; VAGUS NERVE; DELIRIUM; DEPRESSION; PERIPHERAL NERVOUS SYSTEM; SMELLING DISORDER; VISUAL HALLUCINATION;

EID: 84904621098     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt274     Document Type: Review

References (88)

1. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. SA Vann Jones, JT O'Brien, Psychol Med 2014 44 673 683 10.1017/S0033291713000494 23521899
2. Diagnosis and management of dementia with Lewy bodies. IG McKeith, DW Dickson, J Lowe, M Emre, JT O'Brien, H Feldman, J Cummings, JE Duda, C Lippa, EK Perry, D Aarsland, H Arai, CG Ballard, B Boeve, DJ Burn, D Costa, T Del Ser, B Dubois, D Galasko, S Gauthier, CG Goetz, E Gomez-Tortosa, G Halliday, LA Hansen, J Hardy, T Iwatsubo, RN Kalaria, D Kaufer, RA Kenny, A Korczyn, et al. Neurology 2005 65 1863 1872 10.1212/01.wnl.0000187889.17253.b1 16237129 (Pubitemid 43970103)
3. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia. C Metzler-Baddeley, Cortex 2007 43 583 600 10.1016/S0010-9452(08)70489-1 17715794 (Pubitemid 47050642)
4. Clinical diagnostic criteria for dementia associated with Parkinson's disease. M Emre, D Aarsland, R Brown, DJ Burn, C Duyckaerts, Y Mizuno, GA Broe, J Cummings, DW Dickson, S Gauthier, J Goldman, C Goetz, A Korczyn, A Lees, R Levy, I Litvan, I McKeith, W Olanow, W Poewe, N Quinn, C Sampaio, E Tolosa, B Dubois, Mov Disord 2007 22 1689 1707 quiz 1837 10.1002/mds.21507 17542011 (Pubitemid 47597592)
5. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders Arlington, VA: American Psychiatric Publishing 5 2013
6. Formation and development of Lewy pathology: a critical update. KA Jellinger, J Neurol 2009 256 Suppl 3 270 279 19711116
7. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. TG Beach, CH Adler, L Lue, LI Sue, J Bachalakuri, J Henry-Watson, J Sasse, S Boyer, S Shirohi, R Brooks, J Eschbacher, CL White 3rd, H Akiyama, J Caviness, HA Shill, DJ Connor, MN Sabbagh, DG Walker, Arizona Parkinson's Disease Consortium, Acta Neuropathol 2009 117 613 634 10.1007/s00401-009-0538-8 19399512
8. Lewy body-related alpha-synucleinopathy in the aged human brain. KA Jellinger, J Neural Transm 2004 111 1219 1235 10.1007/s00702-004-0138-7 15480835 (Pubitemid 39468387)
9. The progression of pathology in longitudinally followed patients with Parkinson's disease. G Halliday, M Hely, W Reid, J Morris, Acta Neuropathol 2008 115 409 415 10.1007/s00401-008-0344-8 18231798
10. Commentary: DLB and PDD: the same or different? Is there a debate? I McKeith, Int Psychogeriatr 2009 21 220 224 10.1017/S1041610208008624 19173763
11. Prodromal dementia with Lewy bodies. P Donaghy, JT O'Brien, A Thomas, Psychol Med 2014 1 10 Epub ahead of print. [ http://journals.cambridge.org/ action/displayAbstract?fromPage=online&aid=9223458&fileId= S0033291714000816 ]
12. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. P Nelson, G Jicha, R Kryscio, E Abner, F Schmitt, G Cooper, L Xu, C Smith, W Markesbery, J Neurol 2010 257 359 366 10.1007/s00415-009-5324-y 19795154
13. Mild cognitive impairment: clinical characterization and outcome. RC Petersen, GE Smith, SC Waring, RJ Ivnik, EG Tangalos, E Kokmen, Arch Neurol 1999 56 303 308 10.1001/archneur.56.3.303 10190820 (Pubitemid 29120227)
14. Rate of progression of mild cognitive impairment to dementia-meta- analysis of 41 robust inception cohort studies. AJ Mitchell, M Shiri-Feshki, Acta Psychiatr Scand 2009 119 252 265 10.1111/j.1600-0447.2008.01326.x 19236314
15. Mild cognitive impairment: ten years later. RC Petersen, RO Roberts, DS Knopman, BF Boeve, YE Geda, RJ Ivnik, GE Smith, CR Jack Jr, Arch Neurol 2009 66 1447 1455 20008648
16. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. P Fischer, S Jungwirth, S Zehetmayer, S Weissgram, S Hoenigschnabl, E Gelpi, W Krampla, KH Tragl, Neurology 2007 68 288 291 10.1212/01.wnl.0000252358. 03285.9d 17242334 (Pubitemid 46148341)
17. Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. S Palmqvist, J Hertze, L Minthon, C Wattmo, H Zetterberg, K Blennow, E Londos, O Hansson, PLoS One 2012 7 38639 10.1371/journal.pone.0038639 22761691
18. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. S Bombois, S Debette, A Bruandet, X Delbeuck, C Delmaire, D Leys, F Pasquier, Stroke 2008 39 2046 2051 10.1161/STROKEAHA.107. 505206 18436882
19. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. TJ Ferman, GE Smith, K Kantarci, BF Boeve, VS Pankratz, DW Dickson, NR Graff-Radford, Z Wszolek, J Van Gerpen, R Uitti, O Pedraza, ME Murray, J Aakre, J Parisi, DS Knopman, RC Petersen, Neurology 2013 81 2032 2038 10.1212/01.wnl.0000436942.55281.47 24212390
20. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. GA Jicha, JE Parisi, DW Dickson, K Johnson, R Cha, RJ Ivnik, EG Tangalos, BF Boeve, DS Knopman, H Braak, RC Petersen, Arch Neurol 2006 63 674 681 10.1001/archneur.63.5.674 16682537
21. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. J Molano, B Boeve, T Ferman, G Smith, J Parisi, D Dickson, D Knopman, N Graff-Radford, Y Geda, J Lucas, K Kantarci, M Shiung, C Jack, M Silber, VS Pankratz, R Petersen, Brain 2010 133 540 556 10.1093/brain/awp280 19889717
22. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. GA Jicha, FA Schmitt, E Abner, PT Nelson, GE Cooper, CD Smith, WR Markesbery, Neurobiol Aging 2010 31 1805 1813 10.1016/j.neurobiolaging.2008.09. 017 19026468
23. History of a suspected delirium is more common in dementia with Lewy bodies than Alzheimer's disease: a retrospective study. E Vardy, R Holt, A Gerhard, A Richardson, J Snowden, D Neary, Int J Geriatr Psychiatry 2014 29 178 181 10.1002/gps.3986 23722989
24. Early and presenting symptoms of dementia with lewy bodies. E Auning, A Rongve, T Fladby, J Booij, T Hortobagyi, FJ Siepel, C Ballard, D Aarsland, Dement Geriatr Cogn Disord 2011 32 202 208 10.1159/000333072 22095040
25. The neuropathology, pathophysiology and genetics of multiple system atrophy. Z Ahmed, YT Asi, A Sailer, AJ Lees, H Houlden, T Revesz, JL Holton, Neuropathol Appl Neurobiol 2012 38 4 24 10.1111/j.1365-2990.2011.01234.x 22074330
26. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. A Iranzo, E Tolosa, E Gelpi, JL Molinuevo, F Valldeoriola, M Serradell, R Sanchez-Valle, I Vilaseca, F Lomena, D Vilas, A Lladó C Gaig, J Santamaria, Lancet Neurol 2013 12 443 453 10.1016/S1474-4422(13)70056-5 23562390
27. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. RB Postuma, JF Gagnon, M Vendette, ML Fantini, J Massicotte-Marquez, J Montplaisir, Neurology 2009 72 1296 1300 10.1212/01.wnl.0000340980.19702.6e 19109537
28. Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16-year update on a previously reported series. CH Schenck, BF Boeve, MW Mahowald, Sleep Med 2013 14 744 748 10.1016/j.sleep.2012.10.009 23347909
29. Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer's disease. Y Chiba, H Fujishiro, E Iseki, K Ota, K Kasanuki, Y Hirayasu, K Satoa, Dement Geriatr Cogn Disord 2012 33 273 281 10.1159/000339363 22722638
30. Dementia with Lewy bodies: early diagnostic challenges. H Fujishiro, E Iseki, S Nakamura, K Kasanuki, Y Chiba, K Ota, N Murayama, K Sato, Psychogeriatrics 2013 13 128 138 10.1111/psyg.12005 23909972
31. Risk factors for dementia with Lewy bodies: a case-control study. BP Boot, CF Orr, JE Ahlskog, TJ Ferman, R Roberts, VS Pankratz, DW Dickson, J Parisi, JA Aakre, YE Geda, DS Knopman, RC Petersen, BF Boeve, Neurology 2013 81 833 840 10.1212/WNL.0b013e3182a2cbd1 23892702
32. Staging of brain pathology related to sporadic Parkinson's disease. H Braak, K Del Tredici, U Rub, RA de Vos, EN Jansen Steur, E Braak, Neurobiol Aging 2003 24 197 211 10.1016/S0197-4580(02)00065-9 12498954 (Pubitemid 36007810)
33. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? R Frigerio, H Fujishiro, TB Ahn, KA Josephs, DM Maraganore, A DelleDonne, JE Parisi, KJ Klos, BF Boeve, DW Dickson, JE Ahlskog, Neurobiol Aging 2011 32 857 863 10.1016/j.neurobiolaging.2009.05.019 19560232
34. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. J Zaccai, C Brayne, I McKeith, F Matthews, PG Ince, Neurology 2008 70 1042 1048 10.1212/01.wnl.0000306697.48738.b6 18362284 (Pubitemid 351451312)
35. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. L Parkkinen, T Kauppinen, T Pirttila, JM Autere, I Alafuzoff, Ann Neurol 2005 57 82 91 10.1002/ana.20321 15562510 (Pubitemid 40053318)
36. Autonomic disorders predicting Parkinson's disease. JA Palma, H Kaufmann, Parkinsonism Relat Disord 2014 20 Suppl 1 94 S98 24262198
37. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. A Minguez-Castellanos, CE Chamorro, F Escamilla-Sevilla, A Ortega-Moreno, AC Rebollo, M Gomez-Rio, A Concha, DG Munoz, Neurology 2007 68 2012 2018 10.1212/01.wnl.0000264429.59379.d9 17548551 (Pubitemid 46869706)
38. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. H Braak, RA de Vos, J Bohl, K Del Tredici, Neurosci Lett 2006 396 67 72 10.1016/j.neulet.2005.11.012 16330147 (Pubitemid 43233790)
39. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. W Marui, E Iseki, T Nakai, S Miura, M Kato, K Ueda, K Kosaka, J Neurol Sci 2002 195 153 159 10.1016/S0022-510X(02)00006-0 11897247 (Pubitemid 34202293)
40. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. L Parkkinen, T Pirttila, I Alafuzoff, Acta Neuropathol 2008 115 399 407 10.1007/s00401-008-0346-6 18297293
41. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. WJ Schulz-Schaeffer, Acta Neuropathol 2010 120 131 143 10.1007/s00401-010-0711-0 20563819
42. Neurobiology of cognitive impairment in Parkinson's disease. KA Jellinger, Expert Rev Neurother 2012 12 1451 1466 10.1586/ern.12.131 23237352
43. Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson's disease. GM Halliday, YJ Song, AJ Harding, J Neural Transm 2011 118 713 719 10.1007/s00702-011-0641-6 21479514
44. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? KA Jellinger, J Attems, Acta Neuropathol 2006 112 253 260 10.1007/s00401-006-0088-2 16804711 (Pubitemid 44275880)
45. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. KA Jellinger, Mov Disord 2012 27 8 30 10.1002/mds.23795 22081500
46. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. PT Francis, EK Perry, Mov Disord 2007 22 Suppl 17 351 S357 18175396
47. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. MA Piggott, EF Marshall, N Thomas, S Lloyd, JA Court, E Jaros, D Burn, M Johnson, RH Perry, IG McKeith, C Ballard, EK Perry, Brain 1999 122 Pt 8 1449 1468 10430831 (Pubitemid 29374123)
48. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. JA Schneider, Z Arvanitakis, W Bang, DA Bennett, Neurology 2007 69 2197 2204 10.1212/01.wnl.0000271090.28148.24 17568013 (Pubitemid 350294674)
49. Research evaluation and prospective diagnosis of dementia with Lewy bodies. OL Lopez, JT Becker, DI Kaufer, RL Hamilton, RA Sweet, W Klunk, ST DeKosky, Arch Neurol 2002 59 43 46 10.1001/archneur.59.1.43 11790229 (Pubitemid 34052554)
50. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. C Ballard, I Ziabreva, R Perry, JP Larsen, J O'Brien, I McKeith, E Perry, D Aarsland, Neurology 2006 67 1931 1934 10.1212/01.wnl. 0000249130.63615.cc 17159096 (Pubitemid 44967366)
51. Amyloid PET imaging in Lewy body disorders. P Donaghy, A Thomas, JT O'Brien, Am J Geriatr Psychiatry 2013 Epub ahead of print. [ http://www.ajgponline.org/article/S1064-7481(13)00168-1/abstract ]
52. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. ML Kraybill, EB Larson, DW Tsuang, L Teri, WC McCormick, JD Bowen, WA Kukull, JB Leverenz, MM Cherrier, Neurology 2005 64 2069 2073 10.1212/01.WNL.0000165987.89198.65 15985574 (Pubitemid 40880995)
53. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. D Weisman, M Cho, C Taylor, A Adame, LJ Thal, LA Hansen, Neurology 2007 69 356 359 10.1212/01.wnl.0000266626.64913.0f 17646627 (Pubitemid 47205662)
54. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. JB Leverenz, R Hamilton, DW Tsuang, A Schantz, D Vavrek, EB Larson, WA Kukull, O Lopez, D Galasko, E Masliah, J Kaye, R Woltjer, C Clark, JQ Trojanowski, TJ Montine, Brain Pathol 2008 18 220 224 10.1111/j.1750-3639.2007.00117.x 18241240 (Pubitemid 351430400)
55. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. H Uchikado, WL Lin, MW DeLucia, DW Dickson, J Neuropathol Exp Neurol 2006 65 685 697 10.1097/01.jnen.0000225908.90052.07 16825955 (Pubitemid 44297259)
56. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. CR Jack Jr, DS Knopman, WJ Jagust, LM Shaw, PS Aisen, MW Weiner, RC Petersen, JQ Trojanowski, Lancet Neurol 2010 9 119 128 10.1016/S1474-4422(09) 70299-6 20083042
57. Neuroimaging results impose new views on Alzheimer's disease-the role of amyloid revised. AM Fjell, KB Walhovd, Mol Neurobiol 2012 45 153 172 10.1007/s12035-011-8228-7 22201015
58. Magnetic resonance imaging in lewy body dementias. R Watson, AM Blamire, JT O'Brien, Dement Geriatr Cogn Disord 2009 28 493 506 10.1159/000264614 19996594
59. Synthesis and in vitro evaluation of alpha-synuclein ligands. L Yu, J Cui, PK Padakanti, L Engel, DP Bagchi, PT Kotzbauer, Z Tu, Bioorg Med Chem 2012 20 4625 4634 10.1016/j.bmc.2012.06.023 22789706
60. alpha-Synuclein as CSF and blood biomarker of dementia with Lewy bodies. K Kasuga, M Nishizawa, T Ikeuchi, Int J Alzheimers Dis 2012 2012 437025 23056991
61. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. TG Beach, CH Adler, LI Sue, L Vedders, L Lue, CL White Iii, H Akiyama, JN Caviness, HA Shill, MN Sabbagh, DG Walker, Acta Neuropathol 2010 119 689 702 10.1007/s00401-010-0664-3 20306269
62. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. TG Beach, CL White 3rd, CL Hladik, MN Sabbagh, DJ Connor, HA Shill, LI Sue, J Sasse, J Bachalakuri, J Henry-Watson, H Akiyama, CH Adler, Arizona Parkinson's Disease Consortium, Acta Neuropathol 2009 117 169 174 10.1007/s00401-008-0450-7 18982334
63. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. KM Shannon, A Keshavarzian, E Mutlu, HB Dodiya, D Daian, JA Jaglin, JH Kordower, Mov Disord 2012 27 709 715 10.1002/mds.23838 21766334
64. Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on 'olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders'. L Parkkinen, L Silveira-Moriyama, JL Holton, AJ Lees, T Revesz, Acta Neuropathol 2009 117 213 214 author reply 217-218 10.1007/s00401-008-0462-3 19031077
65. alpha-Synuclein in cutaneous autonomic nerves. N Wang, CH Gibbons, J Lafo, R Freeman, Neurology 2013 81 1604 1610 10.1212/WNL.0b013e3182a9f449 24089386
66. 123I-MIBG cardiac scintigraphy. H Fujishiro, S Nakamura, M Kitazawa, K Sato, E Iseki, J Neurol Sci 2012 315 115 119 10.1016/j.jns.2011.11.012 22129938
67. 123I-mIBG imaging. A Chirumamilla, MI Travin, Semin Nucl Med 2011 41 374 387 10.1053/j.semnuclmed.2011.04.001 21803188
68. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. RL Albin, JF Burke, RA Koeppe, B Giordani, S Gilman, KA Frey, J Nucl Med 2013 54 887 893 10.2967/jnumed.112.112599 23572495
69. Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease. D Berg, S Behnke, K Seppi, J Godau, S Lerche, P Mahlknecht, I Liepelt-Scarfone, C Pausch, N Schneider, A Gaenslen, K Brockmann, K Srulijes, H Huber, I Wurster, H Stockner, S Kiechl, J Willeit, A Gasperi, K Fassbender, T Gasser, W Poewe, Mov Disord 2013 28 216 219 10.1002/mds.25192 23115051
70. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. A Iranzo, F Lomena, H Stockner, F Valldeoriola, I Vilaseca, M Salamero, JL Molinuevo, M Serradell, J Duch, J Pavia, J Gallego, K Seppi, B Högl, E Tolosa, W Poewe, J Santamaria, Sleep Innsbruck Barcelona (SINBAR) group, Lancet Neurol 2010 9 1070 1077 20846908
71. Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years. JV Pardo, JT Lee, MA Kuskowski, KR Munch, JV Carlis, SA Sheikh, C Surerus, SM Lewis, JR McCarten, H Fink, S McPherson, HH Shah, S Rottunda, MW Dysken, Alzheimers Dement 2010 6 326 333 10.1016/j.jalz.2009.09.005 20447873
72. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. F Clerici, A Del Sole, A Chiti, L Maggiore, M Lecchi, S Pomati, L Mosconi, G Lucignani, C Mariani, Q J Nucl Med Mol Imaging 2009 53 646 657 20016455
73. A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies. H Fujishiro, E Iseki, K Kasanuki, Y Chiba, K Ota, N Murayama, K Sato, J Neurol Sci 2013 334 48 54 10.1016/j.jns.2013.07.013 23927939
74. The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease. A Gaenslen, I Swid, I Liepelt-Scarfone, J Godau, D Berg, Mov Disord 2011 26 653 658 10.1002/mds.23499 21370256
75. Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. RB Postuma, JF Gagnon, A Pelletier, J Montplaisir, Mov Disord 2013 28 597 604 10.1002/mds.25445 23554107
76. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. RB Postuma, AE Lang, JF Gagnon, A Pelletier, JY Montplaisir, Brain 2012 135 1860 1870 10.1093/brain/aws093 22561644
77. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. RB Postuma, JF Gagnon, M Vendette, C Desjardins, JY Montplaisir, Ann Neurol 2011 69 811 818 10.1002/ana.22282 21246603
78. Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. RB Postuma, PA Lanfranchi, H Blais, JF Gagnon, JY Montplaisir, Mov Disord 2010 25 2304 2310 10.1002/mds.23347 20669316
79. 13C-acetate breath test. Y Tanaka, T Kato, H Nishida, M Yamada, A Koumura, T Sakurai, Y Hayashi, A Kimura, I Hozumi, H Araki, M Murase, M Nagaki, H Moriwaki, T Inuzuka, J Neurol 2011 258 421 426 10.1007/s00415-010-5769-z 20938781
80. Revising the definition of Alzheimer's disease: a new lexicon. B Dubois, HH Feldman, C Jacova, JL Cummings, ST Dekosky, P Barberger-Gateau, A Delacourte, G Frisoni, NC Fox, D Galasko, S Gauthier, H Hampel, GA Jicha, K Meguro, J O'Brien, F Pasquier, P Robert, M Rossor, S Salloway, M Sarazin, LC de Souza, Y Stern, PJ Visser, P Scheltens, Lancet Neurol 2010 9 1118 1127 20934914
81. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, A Gamst, DM Holtzman, WJ Jagust, RC Petersen, PJ Snyder, MC Carrillo, B Thies, CH Phelps, Alzheimers Dement 2011 7 270 279 10.1016/j.jalz.2011.03.008 21514249
82. Prodromal Parkinson's disease-using REM sleep behavior disorder as a window. RB Postuma, Parkinsonism Relat Disord 2014 20 Suppl 1 1 S4 24262156
83. Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. BN Dugger, BF Boeve, ME Murray, JE Parisi, H Fujishiro, DW Dickson, TJ Ferman, Mov Disord 2012 27 72 78 10.1002/mds.24003 22038951
84. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. TJ Ferman, BF Boeve, GE Smith, SC Lin, MH Silber, O Pedraza, Z Wszolek, NR Graff-Radford, R Uitti, J Van Gerpen, W Pao, D Knopman, VS Pankratz, K Kantarci, B Boot, JE Parisi, BN Dugger, H Fujishiro, RC Petersen, DW Dickson, Neurology 2011 77 875 882 10.1212/WNL.0b013e31822c9148 21849645
85. Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis. DG Le Couteur, J Doust, H Creasey, C Brayne, BMJ 2013 347 5125 10.1136/bmj.f5125 24018000
86. Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations. D Brooker, JL Fontaine, S Evans, J Bray, K Saad, Int J Geriatr Psychiatry 2014 29 682 693 10.1002/gps.4066 24458456
87. Alzheimer's Disease-Related Dementias Conference Recommendations to the NINDS Council [ http://www.ninds.nih.gov/funding/areas/neurodegeneration/ workshops/adrd2013/ADRD-2013-Report-and-Memorandum-508comp.pdf ]
88. The prion hypothesis in Parkinson's disease: Braak to the future. NP Visanji, PL Brooks, LN Hazrati, AE Lang, Acta Neuropathol Commun 2013 1 2 10.1186/2051-5960-1-2 24252164